TrialArthritis and rheumatism2013

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.

Michelle Petri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.